MabCure, Inc.
MBCI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -43.83 | -0.25 | -0.17 |
| FCF Yield | -1.40% | -2.58% | -3.49% | -1.45% |
| EV / EBITDA | -0.38 | -28.03 | -23.75 | -80.73 |
| Quality | ||||
| ROIC | -17.42% | -7.49% | -7.34% | -2.77% |
| Gross Margin | 100.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | – | 0.56 | 0.75 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 91.12% | 34.37% | -71.99% | -592.74% |
| Safety | ||||
| Net Debt / EBITDA | -0.01 | -0.05 | -0.33 | 1.20 |
| Interest Coverage | -3.80 | -4.93 | -81.41 | -552.54 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |